Overview

Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection

Status:
Terminated
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is determine if a new formulation of Acetadote is at least as effective as the current formulation in the prevention and treatment of acetaminophen overdose related liver injury.
Phase:
Phase 3
Details
Lead Sponsor:
Cumberland Pharmaceuticals
Treatments:
Acetylcysteine
Edetic Acid
N-monoacetylcystine
Pentetic Acid